Solana Co — Director's Dealing 2015

May 14, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2015-05-14

Reporting Person: LaViscount Joyce N (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$2.66	2020-03-15	Class A Common Stock (100000)		Direct

Footnotes

F1: One-third of the shares subject to this option vested on March 16, 2015 and the remaining shares will vest in equal amounts on each of March 16, 2016 and March 16, 2017.

F2: Translated into U.S. dollars from Canadian dollars based on the noon buying rate from the Federal Reserve Bank of USD$1.00 = CAD$1.2086 on May 8, 2015, based on an option exercise price of CAD$3.20.